The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Calcium antagonists for aneurysmal subarachnoid haemorrhage
Open accessAbstract
BACKGROUND: Secondary ischaemia is a frequent cause of poor outcome in patients with subarachnoid haemorrhage (SAH). Its pathogenesis has been incompletely elucidated, but vasospasm probably is a contributing factor. Experimental studies have suggested that calcium antagonists can prevent or reverse vasospasm and have neuroprotective properties. OBJECTIVES: To determine whether calcium antagonists improve outcome in patients with aneurysmal SAH. SEARCH STRATEGY: We searched the Cochrane Stroke Group Trials Register (last searched April 2006), MEDLINE (1966 to March 2006) and EMBASE (1980 to March 2006). We handsearched two Russian journals (1990 to 2003), and contacted trialists and pharmaceutical companies in 1995 and 1996. SELECTION CRITERIA: Randomised controlled trials comparing calcium antagonists with control, or a second calcium antagonist (magnesium sulphate) versus control in addition to another calcium antagonist (nimodipine) in both the intervention and control groups. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted the data and assessed trial quality. Trialists were contacted to obtain missing information. MAIN RESULTS: Sixteen trials, involving 3361 patients, were included in the review; three of the studies were of magnesium sulphate in addition to nimodipine. Overall, calcium antagonists reduced the risk of poor outcome: the relative risk (RR) was 0.81 (95% confidence interval (CI) 0.72 to 0.92); the corresponding number of patients needed to treat was 19 (95% CI 1 to 51). For oral nimodipine alone the RR was 0.67 (95% CI 0.55 to 0.81), for other calcium antagonists or intravenous administration of nimodipine the results were not statistically significant. Calcium antagonists reduced the occurrence of secondary ischaemia and showed a favourable trend for case fatality. For magnesium in addition to standard treatment with nimodipine, the RR was 0.75 (95% CI 0.57 to 1.00) for a poor outcome and 0.66 (95% CI 0.45 to 0.96) for clinical signs of secondary ischaemia. AUTHORS' CONCLUSIONS: Calcium antagonists reduce the risk of poor outcome and secondary ischaemia after aneurysmal SAH. The results for 'poor outcome' depend largely on a single large trial of oral nimodipine; the evidence for other calcium antagonists is inconclusive. The evidence for nimodipine is not beyond all doubt, but given the potential benefits and modest risks of this treatment, oral nimodipine is currently indicated in patients with aneurysmal SAH. Intravenous administration of calcium antagonists cannot be recommended for routine practice on the basis of the present evidence. Magnesium sulphate is a promising agent but more evidence is needed before definite conclusions can be drawn.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage
Allen, G. S., Ahn, H. S., Preziosi, T. J., Battye, R., Boone, S. C., Chou, S. N., Kelly, D. L., Weir, B. K., Crabbe, R. A., Lavik, P. J., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303173081103 · Cited by 1,195
Pickard, J. D., Murray, G. D., Illingworth, R. D., Shaw, M. D. M., Teasdale, G. M., Foy, P. M., Humphrey, P. R. D., Lang, D. A., Nelson, R. J., Richards, P., et al. (1989) · CRC Press eBooks · doi:10.1136/bmj.298.6674.636 · Cited by 1,144
Case-Fatality Rates and Functional Outcome After Subarachnoid Hemorrhage: A Systematic Review
Hop, J. W., Rinkel, G. J. E., Algra, A., & van Gijn, J. (1997) · Stroke · doi:10.1161/01.str.28.3.660 · Cited by 1,093
Self-citationPetruk, K. C., West, M., Mohr, G., Weir, B. K. A., Benoit, B. G., Gentili, F., Disney, L. B., Khan, M. I., Grace, M., Holness, R. O., et al. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.4.0505 · Cited by 549
Shibuya, M., Suzuki, Y., Sugita, K., Saito, I., Sasaki, T., Takakura, K., Nagata, I., Kikuchi, H., Takemae, T., Hidaka, H., et al. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.4.0571 · Cited by 466
Barker, F. G., & Ogilvy, C. S. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.84.3.0405 · Cited by 358
Haley, E. C., Kassell, N. F., Torner, J. C., & _, _. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.78.4.0537 · Cited by 351
Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled Trial
van den Bergh, W. M. (2005) · Stroke · doi:10.1161/01.str.0000160801.96998.57 · Cited by 321
Self-citationRoos, Y. B. W. E. M. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.3.337 · Cited by 316
Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine
Philippon, J., Grob, R., Dagreou, F., Guggiari, M., Rivierez, M., & Viars, P. (1986) · Acta Neurochirurgica · doi:10.1007/bf01456369 · Cited by 289
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: A systematic review
Feigin, V. L., Rinkel, G. J. E., Algra, A., Vermeulen, M., & van Gijn, J. (1998) · Neurology · doi:10.1212/wnl.50.4.876 · Cited by 271
Self-citationMagnesium sulfate therapy after aneurysmal subarachnoid hemorrhage
Veyna, R. S., Seyfried, D., Burke, D. G., Zimmerman, C., Mlynarek, M., Nichols, V., Marrocco, A., Thomas, A. J., Mitsias, P. D., & Malik, G. M. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.96.3.0510 · Cited by 216
Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery
Öhman, J., & Heiskanen, O. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.69.5.0683 · Cited by 182
Hypomagnesemia after Aneurysmal Subarachnoid Hemorrhage
van den Bergh, W. M., Algra, A., van der Sprenkel, J. W. B., Tulleken, C. A. F., & Rinkel, G. J. E. (2003) · Neurosurgery · doi:10.1227/01.neu.0000043984.42487.0e · Cited by 140
Self-citationCalcium antagonists for aneurysmal subarachnoid haemorrhage
Rinkel, G. J. E., Feigin, V. L., Algra, A., van den Bergh, W. M., Vermeulen, M., & van Gijn, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000277.pub2 · Cited by 134
Self-citationÖhman, J. E., Servo, A., & Heiskanen, O. (1991) · Journal of neurosurgery · doi:10.3171/jns.1991.74.1.0008 · Cited by 114
Early intervention with nimodipine in subarachnoid haemorrhage
Neil-Dwyer, G., Mee, E. T., Dorrance, D. E., et al. (1987) · European Heart Journal · doi:10.1093/eurheartj/8.suppl_k.41 · Cited by 93
van den Bergh, W. M., Zuur, J. K., Kamerling, N., van Asseldonk, J. T. H., Rinkel, G. J. E., Tulleken, C. A. F., & Nicolay, K. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.2.0416 · Cited by 79
Self-citationTettenborn, D., & Dýcka, J. (1990) · PubMed · Cited by 75
Study Design and Outcome Measures in Studies on Aneurysmal Subarachnoid Hemorrhage
van der Schaaf, I. C., Ruigrok, Y., Rinkel, G., Algra, A., & van Gijn, J. (2002) · Stroke · doi:10.1161/01.str.0000024110.82735.5a · Cited by 40
Self-citationShin-ichi, S., Yoshio, S., Tsutomu, H., et al. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90754-r · Cited by 35
Di Mascio, R., Marchioli, R., & Tognoni, G. (1994) · PubMed · Cited by 26
Cited by
Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.
Greebe, P., Bromberg, J. E., Rinkel, G. J., Algra, A., & van Gijn, J. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.3.273 · Cited by 4,139
Self-citationConnolly, E. S., Rabinstein, A. A., Carhuapoma, J. R., Derdeyn, C. P., Dion, J., Higashida, R. T., Hoh, B. L., Kirkness, C. J., Naidech, A. M., Ogilvy, C. S., et al. (2012) · Stroke · doi:10.1161/str.0b013e3182587839 · Cited by 3,512
Magnesium in man: implications for health and disease
de Baaij, J. H. F., Hoenderop, J. G. J., & Bindels, R. J. M. (2015) · Physiological Reviews · doi:10.1152/physrev.00012.2014 · Cited by 1,726
Nieuwkamp, D. J., Setz, L. E., Algra, A., Linn, F. H., de Rooij, N. K., & Rinkel, G. J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70126-7 · Cited by 1,507
Self-citationSubarachnoid haemorrhage: diagnosis, causes and management
van Gijn, J., & Rinkel, G. J. E. (2001) · Brain · doi:10.1093/brain/124.2.249 · Cited by 1,353
Self-citation
Metadata
- Authors
- Dorhout Mees, S., Rinkel, G. J., Feigin, V. L., Algra, A., van den Bergh, W. M., Vermeulen, M., & van Gijn, J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2007-07-18
- Volume
- 2008
- Issue
- 4
- Pages
- CD000277-CD000277
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2128973824
- Cited by
- 758
- References
- 25
- FWCI
- 23.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.